Global Precision Cancer Tests Market Growth (Status and Outlook) 2019-2024
Table of Contents
2019-2024 Global Precision Cancer Tests Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Precision Cancer Tests Market Size 2014-2024
- 2.1.2 Precision Cancer Tests Market Size CAGR by Region
- 2.2 Precision Cancer Tests Segment by Type
- 2.2.1 Imaging
- 2.2.2 In Vitro Diagnostic
- 2.2.3 Others
- 2.3 Precision Cancer Tests Market Size by Type
- 2.3.1 Global Precision Cancer Tests Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Precision Cancer Tests Market Size Growth Rate by Type (2014-2019)
- 2.4 Precision Cancer Tests Segment by Application
- 2.4.1 Cancer Research Centers
- 2.4.2 Cancer Hospital
- 2.4.3 Surgical Centers
- 2.4.4 Clinics
- 2.4.5 Others
- 2.5 Precision Cancer Tests Market Size by Application
- 2.5.1 Global Precision Cancer Tests Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Precision Cancer Tests Market Size Growth Rate by Application (2014-2019)
3 Global Precision Cancer Tests by Players
- 3.1 Global Precision Cancer Tests Market Size Market Share by Players
- 3.1.1 Global Precision Cancer Tests Market Size by Players (2017-2019)
- 3.1.2 Global Precision Cancer Tests Market Size Market Share by Players (2017-2019)
- 3.2 Global Precision Cancer Tests Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Precision Cancer Tests by Regions
- 4.1 Precision Cancer Tests Market Size by Regions
- 4.2 Americas Precision Cancer Tests Market Size Growth
- 4.3 APAC Precision Cancer Tests Market Size Growth
- 4.4 Europe Precision Cancer Tests Market Size Growth
- 4.5 Middle East & Africa Precision Cancer Tests Market Size Growth
5 Americas
- 5.1 Americas Precision Cancer Tests Market Size by Countries
- 5.2 Americas Precision Cancer Tests Market Size by Type
- 5.3 Americas Precision Cancer Tests Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Precision Cancer Tests Market Size by Countries
- 6.2 APAC Precision Cancer Tests Market Size by Type
- 6.3 APAC Precision Cancer Tests Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Precision Cancer Tests by Countries
- 7.2 Europe Precision Cancer Tests Market Size by Type
- 7.3 Europe Precision Cancer Tests Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Precision Cancer Tests by Countries
- 8.2 Middle East & Africa Precision Cancer Tests Market Size by Type
- 8.3 Middle East & Africa Precision Cancer Tests Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Precision Cancer Tests Market Forecast
- 10.1 Global Precision Cancer Tests Market Size Forecast (2019-2024)
- 10.2 Global Precision Cancer Tests Forecast by Regions
- 10.2.1 Global Precision Cancer Tests Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Precision Cancer Tests Forecast by Type
- 10.8 Global Precision Cancer Tests Forecast by Application
11 Key Players Analysis
- 11.1 Abbott
- 11.1.1 Company Details
- 11.1.2 Precision Cancer Tests Product Offered
- 11.1.3 Abbott Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Abbott News
- 11.2 BD
- 11.2.1 Company Details
- 11.2.2 Precision Cancer Tests Product Offered
- 11.2.3 BD Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 BD News
- 11.3 Bio-Rad
- 11.3.1 Company Details
- 11.3.2 Precision Cancer Tests Product Offered
- 11.3.3 Bio-Rad Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Bio-Rad News
- 11.4 Cynvenio Biosystems
- 11.4.1 Company Details
- 11.4.2 Precision Cancer Tests Product Offered
- 11.4.3 Cynvenio Biosystems Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Cynvenio Biosystems News
- 11.5 Foundation Medicine
- 11.5.1 Company Details
- 11.5.2 Precision Cancer Tests Product Offered
- 11.5.3 Foundation Medicine Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Foundation Medicine News
- 11.6 Genomic Health
- 11.6.1 Company Details
- 11.6.2 Precision Cancer Tests Product Offered
- 11.6.3 Genomic Health Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Genomic Health News
- 11.7 Illumina
- 11.7.1 Company Details
- 11.7.2 Precision Cancer Tests Product Offered
- 11.7.3 Illumina Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Illumina News
- 11.8 Myriad Genetics
- 11.8.1 Company Details
- 11.8.2 Precision Cancer Tests Product Offered
- 11.8.3 Myriad Genetics Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Myriad Genetics News
- 11.9 NanoString Technologies
- 11.9.1 Company Details
- 11.9.2 Precision Cancer Tests Product Offered
- 11.9.3 NanoString Technologies Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 NanoString Technologies News
- 11.10 QIAGEN
- 11.10.1 Company Details
- 11.10.2 Precision Cancer Tests Product Offered
- 11.10.3 QIAGEN Precision Cancer Tests Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 QIAGEN News
- 11.11 Randox Laboratories
- 11.12 Roche
- 11.13 Philips
- 11.14 Thermo Fisher Scientific
12 Research Findings and Conclusion
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
According to this study, over the next five years the Precision Cancer Tests market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Precision Cancer Tests business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Precision Cancer Tests market by product type, application, key companies and key regions.
This study considers the Precision Cancer Tests value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Imaging
In Vitro Diagnostic
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Precision Cancer Tests market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Precision Cancer Tests market by identifying its various subsegments.
Focuses on the key global Precision Cancer Tests players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Precision Cancer Tests with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Precision Cancer Tests submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.